BMI1 and familial pancreatic carcinoma: In our study, the PANC-1 and ASPC-1 pancreatic cancer cell lines were treated with different concentrations of gemcitabine, the alterations of Bmi1 expression were determined by quantitative real-time PCR, Western blot and immunofluorescence.